Accepted: 17 May 2022
First Online: 8 June 2022
: Ethical approvals were not required for this scoping review.
: Not applicable.
: SRD declaration of interest: none. AR declares receipt of research grants from Abbvie, BMS, Pfizer and Gilead. Lecture fees and honorariums from Abbvie and Gilead. JFD declares receipt of research grants, Lecture fees and honorariums from Abbvie, BMS, Gilead, MSD and Roche.The sponsors had no role in the design, execution, interpretation, or writing of the study.